ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.163,52
-0,41%
S&P 500
5.464,62
-0,16%
Dow Jones
39.150,33
0,04%
Euro vs US Dollar
1,06909
-0,01%
Bitcoin
64.115,48
-0,20%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Eiger Biopharmaceuticals Com (CLDN)

  7. Eiger Biopharmaceuticals Com (CLDN) News

CLDN

CELLADON CORP (CLDN)

Eiger Biopharmaceuticals Com
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CLDN
DatumZeitQuelleÜberschriftSymbolFirma
26/03/201600h21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
26/03/201600h19Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
26/03/201600h17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
26/03/201600h15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
26/03/201600h11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
26/03/201600h08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
26/03/201600h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CLDNEiger Biopharmaceuticals Com
23/03/201611h12Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
21/03/201621h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
21/03/201621h05GlobeNewswire Inc.Celladon Announces Results of Special MeetingNASDAQ:CLDNEiger Biopharmaceuticals Com
14/03/201621h12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
09/03/201622h39Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
09/03/201622h37Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
29/02/201623h27Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
29/02/201614h00PR Newswire (US)Eiger to Participate in Cowen & Company 2016 Health Care ConferenceNASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201620h44Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201620h44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201617h29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201612h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201612h19Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
16/02/201612h01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CLDNEiger Biopharmaceuticals Com
11/02/201623h31Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
11/02/201623h18Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
10/02/201623h16Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
10/02/201623h15Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:CLDNEiger Biopharmaceuticals Com
10/02/201622h58GlobeNewswire Inc.Celladon Sets Date for Special Meeting of StockholdersNASDAQ:CLDNEiger Biopharmaceuticals Com
08/02/201623h25Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
29/01/201613h28Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CLDNEiger Biopharmaceuticals Com
22/01/201612h12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:CLDNEiger Biopharmaceuticals Com
19/01/201622h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CLDNEiger Biopharmaceuticals Com
 Showing the most relevant articles for your search:NASDAQ:CLDN

Kürzlich von Ihnen besucht

POLO
XUSDBTC
XUSD Stablecoin
LSE
ICX
Intercytex
LSE
EBR3
Basf
NASDAQ
SMED
Sharps Compliance
TG
A3KRLV
United Overseas Bank
USOTC
BSFAF
BSF Enterprise (QB)
NASDAQ
WHLR
Wheeler Real Estate Inve...
NASDAQ
FINM
Marlin Technology
NASDAQI
SX402010GI
OMX Stockholm Consumer S...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten